ES552796A0 - Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.

Info

Publication number
ES552796A0
ES552796A0 ES552796A ES552796A ES552796A0 ES 552796 A0 ES552796 A0 ES 552796A0 ES 552796 A ES552796 A ES 552796A ES 552796 A ES552796 A ES 552796A ES 552796 A0 ES552796 A0 ES 552796A0
Authority
ES
Spain
Prior art keywords
sup
procedure
preparation
hydrogen
cyclopenta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES552796A
Other languages
English (en)
Other versions
ES8704905A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Ube Corp
Original Assignee
Sankyo Co Ltd
Ube Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd, Ube Industries Ltd filed Critical Sankyo Co Ltd
Publication of ES8704905A1 publication Critical patent/ES8704905A1/es
Publication of ES552796A0 publication Critical patent/ES552796A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Eyeglasses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Soil Working Implements (AREA)
ES552796A 1985-03-07 1986-03-07 Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina. Expired ES8704905A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4362685 1985-03-07

Publications (2)

Publication Number Publication Date
ES8704905A1 ES8704905A1 (es) 1987-04-16
ES552796A0 true ES552796A0 (es) 1987-04-16

Family

ID=12669058

Family Applications (3)

Application Number Title Priority Date Filing Date
ES552796A Expired ES8704905A1 (es) 1985-03-07 1986-03-07 Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.
ES557198A Expired ES8801221A1 (es) 1985-03-07 1986-11-14 Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES557199A Expired ES8801222A1 (es) 1985-03-07 1986-11-14 Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557198A Expired ES8801221A1 (es) 1985-03-07 1986-11-14 Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES557199A Expired ES8801222A1 (es) 1985-03-07 1986-11-14 Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina

Country Status (15)

Country Link
US (1) US4749704A (es)
EP (1) EP0194161B1 (es)
JP (1) JPS6270A (es)
KR (1) KR890003839B1 (es)
AT (1) ATE106077T1 (es)
AU (1) AU580391B2 (es)
CA (1) CA1273632A (es)
DE (1) DE3689848T2 (es)
DK (1) DK165109C (es)
ES (3) ES8704905A1 (es)
FI (1) FI88717C (es)
HK (1) HK1005450A1 (es)
IE (1) IE64504B1 (es)
NO (1) NO168767C (es)
ZA (1) ZA861708B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
US5877178A (en) * 1991-04-08 1999-03-02 Duquesne University Of The Holy Ghost Pyrimidine derivatives and methods of making and using these derivatives
US5234936A (en) * 1991-10-24 1993-08-10 American Home Products Corporation Pyrimidocycloalkanes as a ii antagonists
ATE374190T1 (de) * 2003-08-12 2007-10-15 Hoffmann La Roche Tetrahydrochinazolinderivate als cfr-antagonisten
JPWO2007049342A1 (ja) 2005-10-26 2009-04-30 三菱電機株式会社 エレベーター群管理制御装置
MY147628A (en) 2006-07-06 2012-12-31 Array Biopharma Inc Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
WO2008006025A1 (en) 2006-07-06 2008-01-10 Array Biopharma Inc. Dihydrofuro pyrimidines as akt protein kinase inhibitors
WO2008006039A1 (en) 2006-07-06 2008-01-10 Array Biopharma Inc. Dihydrothieno pyrimidines as akt protein kinase inhibitors
WO2008021456A2 (en) * 2006-08-16 2008-02-21 Cytovia, Inc. N-aryl-5,7-dihydrofuro[3,4-d]pyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
BRPI0813993A2 (pt) 2007-07-05 2015-06-16 Array Biopharma Inc Ciclopentanos de pirimidila como inibidores de proteína quinase akt
JP5628028B2 (ja) 2007-07-05 2014-11-19 アレイ バイオファーマ、インコーポレイテッド Ａｋｔプロテインキナーゼ阻害剤としてのピリミジルシクロペンタン
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
BRPI0906798A2 (pt) 2008-01-09 2015-07-14 Array Biopharma Inc Pirimidil ciclopentanos hidroxilados como inibidores de proteína quinase akt
EP2240455B1 (en) 2008-01-09 2012-12-26 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
JP5230749B2 (ja) 2008-10-20 2013-07-10 三菱電機株式会社 エレベーター群管理装置
PL2694073T3 (pl) 2011-04-01 2019-06-28 Genentech, Inc. Kombinacje inhibitorów AKT i MEK do leczenia nowotworu
JP6143739B2 (ja) 2011-04-01 2017-06-07 ジェネンテック， インコーポレイテッド Ａｋｔ阻害剤化合物及びベムラフェニブの組み合わせ、及び使用方法
GB201121127D0 (en) 2011-12-08 2012-01-18 Dow Corning Treatment of filler with silane
CN111303053B (zh) * 2020-03-16 2023-01-17 中国海洋大学 环戊并[d]嘧啶类化合物及其药学上可接受的盐、溶剂合物或者前药以及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470182A (en) * 1967-02-09 1969-09-30 Sandoz Ag 4-amino-substituted quinazolines
US3980650A (en) * 1972-05-05 1976-09-14 N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia 4-Amino-pyrimidine derivatives
US3915976A (en) * 1972-09-01 1975-10-28 Sandoz Ag Substituted-4-phenyl-5h-cycloalkano(d)pyrimidines
PH20344A (en) * 1981-01-29 1986-12-04 Sankyo Co Aminopyrimidine derivatives, processes for their preparation, and fungicidal, insecticidal and acaricidal compositions containing them
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient

Also Published As

Publication number Publication date
EP0194161A2 (en) 1986-09-10
FI860969A0 (fi) 1986-03-07
FI88717B (fi) 1993-03-15
NO168767C (no) 1992-04-01
ES8704905A1 (es) 1987-04-16
ES8801222A1 (es) 1988-01-01
KR860007221A (ko) 1986-10-08
HK1005450A1 (en) 1999-01-08
US4749704A (en) 1988-06-07
DK165109B (da) 1992-10-12
IE64504B1 (en) 1995-08-09
DK106586A (da) 1986-09-08
ES557199A0 (es) 1988-01-01
AU580391B2 (en) 1989-01-12
KR890003839B1 (ko) 1989-10-05
JPS6270A (ja) 1987-01-06
IE860597L (en) 1986-09-07
DE3689848T2 (de) 1995-01-12
AU5448186A (en) 1986-09-11
EP0194161B1 (en) 1994-05-25
DK165109C (da) 1993-03-01
ZA861708B (en) 1986-11-26
FI88717C (fi) 1993-06-28
NO860852L (no) 1986-09-08
EP0194161A3 (en) 1987-09-02
FI860969A (fi) 1986-09-08
ATE106077T1 (de) 1994-06-15
ES557198A0 (es) 1988-01-01
NO168767B (no) 1991-12-23
ES8801221A1 (es) 1988-01-01
DK106586D0 (da) 1986-03-07
DE3689848D1 (de) 1994-06-30
CA1273632A (en) 1990-09-04

Similar Documents

Publication Publication Date Title
ES552796A0 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
ZA858418B (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazoline-3-one compounds and methods for the preparation thereof,intermediates for use in the preparation of said compounds and medicaments containing said compounds
LV10422A (lv) Jaunie fluor-naftacendioni to glikozetie atvasinajumi un vinu razosanas panemiens
ES550742A0 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
ATE77950T1 (de) Octahydroindolizine analgesica und 7-ketozwischenprodukte.
KR910006310A (ko) 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체
JO1676B1 (en) Extra compounds indinol II
ATE32216T1 (de) Diphenylmethylimin-derivate.
ES550781A0 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010226